From: Phillip Windham [phillipb7@earthlink.net] Sent: Monday, September 04, 2006 7:25 PM To: Dockets, FDA Subject: RE: Review paper documenting adverse neurological effects ofdent al amalgam use I sent the documentation for Docket No. 2006N-0352 that was the purpose that I compiled the information for that was true for all of my documentation see included: ----- Original Message ----- From: Boler-Bonny, Adrian L* To: phillipb7@earthlink.net Sent: 9/1/2006 11:21:12 AM Subject: RE: Review paper documenting adverse neurological effects ofdent al amalgam use Dear concerned citizen, We received your email regarding the upcoming September 6-7 meeting on dental amalgam. If you would like your comments to be publicly available, please resend your email to the following docket, which has been established for this meeting. Docket No. 2006N-0352 Please remember that the docket is open to the public, so be mindful of any personal information you include in your email. To submit comments, resend your email to FDADockets@oc.fda.gov and reference Docket Number 2006N-0352 or visit http://www.fda.gov/dockets/ecomments , select "Docket Search," type in Docket Number 2006N-0352 under "Docket ID," and then follow instructions provided. __________________________ Michael E. Adjodha Executive Secretary Dental Products Panel DHHS/FDA/CDRH/ODE Mail Stop: HFZ-480 Room: 9200 Corp., 330L Phone: 301-827-5283, ext. 123 Fax: 301-480-3002 E-mail: michael.adjodha@fda.hhs.gov ---------------------------------------------------------------------------- From: Phillip Windham [mailto:phillipb7@earthlink.net] Sent: Tuesday, August 22, 2006 11:34 AM To: Adjodha, Michael E Subject: Review paper documenting adverse neurological effects of dental amalgam use I tried to send this paper which is a large attachment on another email and got an error message. So in case it didn't go through, I;ll try again. I don't know much about size limits which may have been the problem www.flcv.com/neurohgf.html Bernard Windham 12164 Whitehouse Rd Tallahassee Fl 32317 850-878-9024 Research Director DAMS Intl